drugset / Trial / NCT06350448

Washed Microbiota Transplantation for Rhinitis

NCT06350448

Not yet recruiting 40 enrolled The Second Hospital of Nanjing Medical University
NaSingle-groupOpen-labelTreatment

Summary

The common symptoms of rhinitis include nasal itching, sneezing, anterior or posterior nasal leakage, and nasal congestion. Rhinitis can be classified as allergic rhinitis (AR) and non-allergic rhinitis (NAR) based on the presence of a specific allergen. Increasing evidence showed that gut microbiota can influence the development of AR. Although few studies have reported the association between NAR and gut microbiota, we found that washed microbiota transplantation (WMT) could improve nasal symptoms, whether it is AR or NAR. This clinical trial aims to evaluate the efficacy and safety of WMT for rhinitis.

Timeline

Start
2024-05-01
Primary completion
2029-05-01
Completion
2029-08-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornidazole Other / unclassified 5 unknown Other

Indications